why choose us

First received: June 07, 2023

Clinical Trial: A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Multiple System Atrophy (MSA)

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Potential Efficacy of Multiple Doses of ONO-2808 in Patien

Brief Summary: This is a Phase 2, double-blind, parallel-group, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of multiple doses of ONO-2808 in patients with MSA.This is the first study of ONO-2808 in patients with MSA.

Read more